Search for: "MedImmune, Inc. v. Genentech, Inc." Results 121 - 140 of 153
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2022, 6:12 pm by Dennis Crouch
  This question ties the case directly to MedImmune, Inc. v. [read post]
14 Dec 2021, 9:57 am by Dennis Crouch
  As you can see, this question attempts to tie the case directly to MedImmune, Inc. v. [read post]
27 Jul 2009, 6:40 am
It has been stated that applicants abuse the system by filing divisional patent applications which incorporate new or revised claims to obtain multiple patents that all cover [*863] essentially the same invention. n35 In the case of MedImmune, Inc. v. [read post]
28 Mar 2009, 4:40 pm
., Craig Allen Nard, The Law of Patents 34 (2008) (asserting PTO grants patents on 39% of applications); Brief of the Boston Patent Law Ass'n as Amicus Curiae in Support of Genentech, Inc., on the Merits at 5, Medimmune, Inc. v. [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks invalidation of… [read post]
6 Nov 2015, 6:58 am
  Therefore, it was not obvious to test pregabalin – it might be obvious to test gabapentin, but even here the judge considered that the skilled team would have little expectation of success.InsufficiencyAccording to the caselaw relating to sufficiency developed in MedImmune Ltd v Novartis Pharmaceuticals UK Ltd [2011] EWHC 1699 (Pat) at [458]-[484] and summarised in Sandvik Intellectual Property AB v Kennametal UK Ltd [2011] EWHC 3311 (Pat) at… [read post]